Joanne Wuensch
Stock Analyst at Citigroup
(4.29)
# 426
Out of 5,041 analysts
418
Total ratings
63.21%
Success rate
11.35%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Buy | $213 → $215 | $192.47 | +11.71% | 15 | Oct 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $11 → $15 | $14.66 | +2.32% | 20 | Oct 7, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $4.5 → $4 | $5.21 | -23.22% | 13 | Oct 7, 2025 | |
| MDT Medtronic | Maintains: Buy | $101 → $112 | $94.21 | +18.88% | 22 | Oct 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $183 → $205 | $182.27 | +12.47% | 21 | Oct 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $10 → $12 | $15.88 | -24.43% | 15 | Oct 7, 2025 | |
| HAE Haemonetics | Maintains: Buy | $78 → $64 | $51.35 | +24.63% | 9 | Oct 7, 2025 | |
| GKOS Glaukos | Maintains: Buy | $140 → $110 | $75.26 | +46.16% | 21 | Oct 7, 2025 | |
| DXCM DexCom | Maintains: Buy | $105 → $85 | $71.06 | +19.62% | 15 | Oct 7, 2025 | |
| GEHC GE HealthCare Technologies | Downgrades: Neutral | $93 → $83 | $77.26 | +7.43% | 7 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $97 → $72 | $74.52 | -3.38% | 21 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $157 → $155 | $126.34 | +22.68% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $320 → $285 | $253.51 | +12.42% | 25 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $47 | $49.44 | -4.94% | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $34 → $32 | $22.99 | +39.19% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $15.78 | -4.94% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $443 → $455 | $383.06 | +18.78% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.59 | +161.01% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $551.30 | +17.90% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $323.46 | +17.48% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $95 | $76.53 | +24.13% | 20 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $102.39 | +22.08% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $73.89 | +89.47% | 6 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $103.16 | +16.32% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $186.53 | +34.03% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $76.26 | -9.52% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $265.26 | -52.12% | 6 | Dec 10, 2018 |
Johnson & Johnson
Oct 15, 2025
Maintains: Buy
Price Target: $213 → $215
Current: $192.47
Upside: +11.71%
Tandem Diabetes Care
Oct 7, 2025
Maintains: Neutral
Price Target: $11 → $15
Current: $14.66
Upside: +2.32%
Sight Sciences
Oct 7, 2025
Maintains: Neutral
Price Target: $4.5 → $4
Current: $5.21
Upside: -23.22%
Medtronic
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $94.21
Upside: +18.88%
iRhythm Technologies
Oct 7, 2025
Maintains: Buy
Price Target: $183 → $205
Current: $182.27
Upside: +12.47%
Integra LifeSciences Holdings
Oct 7, 2025
Maintains: Sell
Price Target: $10 → $12
Current: $15.88
Upside: -24.43%
Haemonetics
Oct 7, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $51.35
Upside: +24.63%
Glaukos
Oct 7, 2025
Maintains: Buy
Price Target: $140 → $110
Current: $75.26
Upside: +46.16%
DexCom
Oct 7, 2025
Maintains: Buy
Price Target: $105 → $85
Current: $71.06
Upside: +19.62%
GE HealthCare Technologies
Oct 7, 2025
Downgrades: Neutral
Price Target: $93 → $83
Current: $77.26
Upside: +7.43%
Aug 28, 2025
Downgrades: Neutral
Price Target: $97 → $72
Current: $74.52
Upside: -3.38%
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $126.34
Upside: +22.68%
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $253.51
Upside: +12.42%
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $49.44
Upside: -4.94%
Jul 9, 2025
Maintains: Neutral
Price Target: $34 → $32
Current: $22.99
Upside: +39.19%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $15.78
Upside: -4.94%
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $383.06
Upside: +18.78%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.59
Upside: +161.01%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $551.30
Upside: +17.90%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $323.46
Upside: +17.48%
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $76.53
Upside: +24.13%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $102.39
Upside: +22.08%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $73.89
Upside: +89.47%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $103.16
Upside: +16.32%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $186.53
Upside: +34.03%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $76.26
Upside: -9.52%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $265.26
Upside: -52.12%